Literature DB >> 1092611

T cell-dependent helper and suppressive influences in an adoptive IgG antibody response.

S Arrenbrecht, G F Mitchell.   

Abstract

When immune spleen cells of mice immunized to a hapten carrier preparation 4 days previously were transferred to normal syngeneic hosts, they began to produce 7S antibody (presumably of the IgG class), provided that relatively small numbers of cells (about 1/10 spleen equivalent) were transferred. Increasing the number of transferred cells resulted in less IgG antibody formed. Depletion of the immune spleen cells of T cells by treatment with anti-theta serum and complement prevented IgG antibody formation. IgG antibody production by untreated and anti-therta serum-treated immune spleen cells could be enhanced (reinduced) by addition of small numbers of cells enriched for carrier-activated T cells. These suggest that T cells are necessary to stimulate antigen-activated B cells into IgG antibody production. Larger numbers of 'carrier-activated T cells' depressed IgG antibody production. Both enhancement and depression could be demonstrated to be antigen-specific. IgG antibody production high numbers of transferred immune spleen cells could be induced by treating the cells prior to transfer with suboptimal amounts of anti-theta serum and complement. It is argued that this results from the elimination of a T cell-dependent suppressor influence arising during a normal immune response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092611      PMCID: PMC1445786     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Lymphoid tissue architecture. Experimental analysis of the origin and distribution of T-cells and B-cells.

Authors:  G A Gutman; I L Weissman
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

Review 2.  Immunoglobulin receptors on B lymphocytes: shifts in immunoglobulin class during immune responses.

Authors:  C W Pierce; R Asofsky; S M Solliday
Journal:  Fed Proc       Date:  1973-01

3.  Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott; R F Barth
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

4.  Normal development of the thymus-dependent limb of humoral immune responses in mice.

Authors:  S Arrenbrecht
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

5.  The mechanism of immunological unresponsiveness to picryl chloride and the possible role of antibody mediated depression.

Authors:  G L Asherson; M Zembala; R M Barnes
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

6.  Inhibition by anti- chain sera of the cellular transfer of antibody and immunoglobulin synthesis in mice.

Authors:  H G Herrod; N L Warner
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

7.  Amplifying and suppressive effect of thymus cells.

Authors:  W Droege
Journal:  Nature       Date:  1971-12-31       Impact factor: 49.962

8.  Infectious immunological tolerance.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

9.  Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera.

Authors:  D D Manning; J W Jutila
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

10.  Cell-to-cell interaction in the immune response. IX. Regulation of hepten-specific antibody class by carrier priming.

Authors:  C Cheers; J F Miller
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  2 in total

1.  A suppressor mechanism controlling lymphocyte recruitment.

Authors:  C J Elson; C P Sullivan
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

2.  Suppression of IgE-antibody production by non-polypeptide dialysable thymic factor.

Authors:  I Bezvershenko; E Gjulling; L Dyugovskaya
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.